Page last updated: 2024-10-26

disulfiram and Atrioventricular Nodal Re-Entrant Tachycardia

disulfiram has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Treatment of cardiac arrhythmia remains challenging due to severe side effects of common anti-arrhythmic drugs."1.62Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca ( Arduino, DM; Dreizehnter, L; Feng, M; Fischbach, S; Gudermann, T; Gutenthaler, SM; Moretti, A; Perocchi, F; Sander, P; Schredelseker, J; Schweitzer, MK; Wilting, F, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sander, P1
Feng, M1
Schweitzer, MK1
Wilting, F1
Gutenthaler, SM1
Arduino, DM1
Fischbach, S1
Dreizehnter, L1
Moretti, A1
Gudermann, T1
Perocchi, F1
Schredelseker, J1

Other Studies

1 other study available for disulfiram and Atrioventricular Nodal Re-Entrant Tachycardia

ArticleYear
Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca
    British journal of pharmacology, 2021, Volume: 178, Issue:22

    Topics: Animals; Arrhythmias, Cardiac; Calcium; Calcium Signaling; Disulfiram; Ezetimibe; HeLa Cells; Humans

2021